非商业临床试验预算工具:公共资助机构的开发经验
KCE Trials项目作为公共资助方,开发了一套临床试验预算工具,用于高效、透明、公平地预算非商业多中心随机试验。该工具已用于2016年以来资助的17项试验,并与其他降低风险措施结合使用。
要点
- 预算工具涵盖申办方和参与中心的全部试验活动与成本驱动因素。
- 工具已用于17项试验,并与分步筛选、预付款、可行性核查等风险控制措施配合。
- 该工具有助于在预算内按时高质量完成试验,以产生对患者和医疗支付方的影响。
核心结论
- 预算工具有助于KCE Trials项目在预算内按时高质量地回答相关研究问题。
研究设计与样本
- 由公共资助机构KCE Trials项目开发预算工具,对所有试验相关活动进行分类并识别成本驱动因素。
- 工具以电子表格形式纳入申办方团队可详细计算各项活动及成本驱动因素影响的内容。
- 各角色小时费率改编自已发表数据,适当时为每项活动设定固定金额。
主要发现
- 该公开可用工具已用于2016年KCE Trials项目启动以来资助的17项试验,并持续使用和改进。
- 工具与多步筛选及预付款、申办方和资助方的招募可行性检查、密切监测研究进展、基于里程碑的付款计划(最后一笔在稿件提交时支付)等风险降低措施配合使用。
临床怎么用
- 申办方团队可用该工具详细计算临床试验各项活动,并评估特定成本驱动因素(如招募延迟)的预算影响。
- 该工具可与非商业试验的其他风险降低措施结合,以促进试验按时、按预算、高质量完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Investigator-led multicentre randomised trials are essential to generate evidence on the optimal use of medical interventions. These non-commercial trials are often hampered by underfunding, which may lead to difficulties in gathering a team with the necessary expertise, a delayed trial start, slow recruitment and even early trial discontinuation. As a new public funder of pragmatic clinical trials, the KCE Trials programme was committed to correctly pay all trial activities in order to assure timely delivery of high-quality trial results. As no appropriate trial budget tool was readily publicly available that took into account the costs for the sponsor as well as the costs for participating sites, we developed a tool to make the budgeting of a clinical trial efficient, transparent and fair across applicants. METHODS: All trial-related activities of the sponsor and sites were categorised, and cost drivers were identified. All elements were included in a spreadsheet tool allowing the sponsor team to calculate in detail the various activities of a clinical trial and to appreciate the budget impact of specific cost drivers, e.g. a delay in recruitment. Hourly fees by role were adapted from published data. Fixed amounts per activity were developed when appropriate. RESULTS: This publicly available tool has already been used for 17 trials funded since the start of the KCE Trials programme in 2016, and it continues to be used and improved. This budget tool is used together with additional risk-reducing measures such as a multistep selection process with advance payments, a recruitment feasibility check by sponsor and funder, a close monitoring of study progress and a milestone-based payment schedule with the last payment made when the manuscript is submitted. CONCLUSIONS: The budget tool helps the KCE Trials programme to answer relevant research questions in a timely way, within budget and with high quality, a necessary condition to achieve impact of this programme for patients, clinical practice and healthcare payers.
引用
- Nevens H, Harrison J, Vrijens F, et al. Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency. Trials. 2019. PMID: 31829233. doi:10.1186/s13063-019-3900-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。